Sophia Genetics SA (SOPH) stock price

Sophia Genetics SA (SOPH) is a Healthcare · Health Information Services company listed on NASDAQ. Price $8.25 (-3.28%), Market cap $0.34B, 52-week low–high $2.85 ~ $5.52.

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company was incorporated in 2011 and is based in Rolle, Switzerland.

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Sophia Genetics SA are updated in real time on BlackAll Trade.

Sophia Genetics SA financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Sophia Genetics SA (SOPH) stock price?

Sophia Genetics SA trades at $8.25 (-3.28%). Real-time quotes and charts are available on BlackAll Trade.

What is the Sophia Genetics SA (SOPH) market cap?

Sophia Genetics SA has a market cap of about $0.34B.

What does Sophia Genetics SA (SOPH) do?

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating ins